FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

(MedPage Today) — The FDA issued a warning letter to Novo Nordisk for failing to report and investigate potentially serious side effects associated with its popular GLP-1 medications.
In a letter dated March 5 and made public on Tuesday, the…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/120262

Author :

Publish date : 2026-03-11 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

Drug Cuts Treatment Modifications From Chemotherapy-Induced Thrombocytopenia

Traditional Medicare Enrollees Paid Billions More in Premiums Due to MA Overpayments

Related Posts

AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients

‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?

Omalizumab Plus Immunotherapy May Ease Allergic Asthma

First Gene Therapy Approved for Hearing Loss

Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says

FDA, CMS to Launch Speedy Coverage Pathway for Breakthrough Medical Devices

AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients

‘Ozempic Personality’: Is Emotional Flattening Another Side Effect of GLP-1s?

Omalizumab Plus Immunotherapy May Ease Allergic Asthma

First Gene Therapy Approved for Hearing Loss

Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says

FDA, CMS to Launch Speedy Coverage Pathway for Breakthrough Medical Devices

DMR Slows Post-Tirzepatide Weight Regain

The Most Lethal Cancers Get Shortchanged by Federal Funding, Study Shows

Categories

Archives